case_images: PMC11188395_01
case_images: (A) MR Sagittal image of the patient before treatment, with the blue arrow showing cervical lesions; (B) coronal T2 images of the patient before treatment, with white arrows showing bilateral uterine bodies; (C) sagittal image of the patient before treatment. (D-F) Re-examination images of the patient 1 year after the end of treatment showed that the lesion was not visible, and the efficacy evaluation was CR.
case_images: fonc-14-1361562-g001.jpg
case_images: PMC11188395_01_fonc-14-1361562-g001.jpg
case_images: f1
case_images: Positron Emission Tomography-Computed Tomography (PET-CT) examination. Pelvic magnetic resonance imaging (MRI) showed a cervical tumor measuring 2.7 cm x 2.3 cm x 1.7 cm, which had invaded the left parametrial and vaginal fornix ( Figure 1 ).
case_images: Schematic diagram of applicators, in which one tandem is fixed with a connecting assembly, the upper part of the other tandem is fixed with gauze inside the vagina and the lower part with tape (red arrow indicated).
case_images: fonc-14-1361562-g002.jpg
case_images: PMC11188395_01_fonc-14-1361562-g002.jpg
case_images: f2
case_images: Brachytherapy applicator was selected with CT-compatible tandems and ovoids ( Figure 2 ).
case_images: Brachytherapy treatment plan. (A, B) Dose distribution of patients in coronal and sagittal positions. The red dashed line in the figure is HRCTV. (C) The reconstructed image of the applicators, HRCTV and uterus.
case_images: fonc-14-1361562-g003.jpg
case_images: PMC11188395_01_fonc-14-1361562-g003.jpg
case_images: f3
case_images: One of the treatment plans and applicators reconstruction images is shown in  Figure 3 .